tirzepatide and diabetic retinopathy Ocular Outcomes with versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Tirzepatide and diabetic eye disease

Managing Potential Side Effects and Drug Interactions Nausea and gastrointestinal effects are the most commonly reported adverse events with tirzepatide, occurring in 2030% of users during dose escalation phases

HACE is characterized by sudden onset, rapid worsening of symptoms, and a notably elevated mortality risk ( China has the worlds largest expanse of high-altitude territories

SURMOUNT trials showed significant weight loss on tirzepatide but didn't focus on body composition

How long should I expect to be on the medication before seeing results

In rare cases, it can also cause serious cardiovascular side effects, including heart attack, stroke, and sudden cardiac death (heart suddenly stops beating)